Amedeo Smart

Free Medical Literature Service

 

Amedeo

Lung Cancer
  Free Subscription

Articles published in
Int J Radiat Oncol Biol Phys
    October 2025
  1. MORRIS T, Muradova Z, Brown N, Carmes L, et al
    Second-Generation Gadolinium-Bismuth Ultrasmall Nanoparticles Amplify the Effects of Clinical Radiation Therapy and Provide Clinical Magnetic Resonance Imaging Contrast.
    Int J Radiat Oncol Biol Phys. 2025;123:572-582.
    >> Share

    September 2025
  2. MEHTA MP, Gondi V, Ahluwalia MS, Roberge D, et al
    Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06217.
    >> Share

  3. DANG A, Palma DA, Wang E, Lang P, et al
    Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial.
    Int J Radiat Oncol Biol Phys. 2025 Sep 29:S0360-3016(25)06288.
    >> Share

  4. LI Q, Ma H, Zheng R, Cai L, et al
    Durvalumab combined with chemotherapy and Stereotactic Ablative Body Radiotherapy (SABR) in patients with oligometastatic non-small cell lung cancer: a multi-center phase 2 study.
    Int J Radiat Oncol Biol Phys. 2025 Sep 24:S0360-3016(25)06304.
    >> Share

  5. ARCIDIACONO F, Anselmo P, Casale M, Zannori C, et al
    5-year survival and safety of stereotactic ablative radiotherapy in unresectable locally advanced non-small cell lung cancer patients unfit for concurrent radio-chemotherapy:focus on patterns of local recurrence from the START-NEW-ERA non-randomized p
    Int J Radiat Oncol Biol Phys. 2025 Sep 22:S0360-3016(25)06209.
    >> Share

  6. FRIEDES C, Yegya-Raman N, Iocolano M, Levin WP, et al
    Primary Tumor Failure after Definitive Chemoradiation in Locally Advanced Non-Small Cell Lung Cancer: A Brief Report on the Implications for NRG LU-008.
    Int J Radiat Oncol Biol Phys. 2025 Sep 16:S0360-3016(25)06276.
    >> Share

  7. RUTKOWSKI J, Nowicka Z, Sobocki BK, Slebioda T, et al
    Patterns of immunity changes predict response to stereotactic ablative radiotherapy in early non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Sep 3:S0360-3016(25)06206.
    >> Share

    August 2025
  8. WANG W, Ren M, Ren J, Dang J, et al
    Predicting Radiation Pneumonitis Integrating Clinical Information, Medical Text, and 2.5D Deep Learning Features in Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Aug 21:S0360-3016(25)06035.
    >> Share

  9. GEWIRTZ A, Yang JT
    Leptomeningeal Spread in EGFR-Mutant Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1086-1087.
    >> Share

  10. ROGAWSKI D, Nagpal S
    Hold Your Fire: The Case for Targeted Therapy, Not Radiation, for EGFR-mutant Non-small Cell Lung Cancer Leptomeningeal Disease.
    Int J Radiat Oncol Biol Phys. 2025;122:1084.
    >> Share

  11. GAL O, Kotecha R
    Leptomeningeal Spread in EGFR Mutation Non-Small Cell Lung Cancer: No More One Size Fits All.
    Int J Radiat Oncol Biol Phys. 2025;122:1084-1086.
    >> Share

  12. HAISRAELY O, Tom MC
    Beneath the Surface: Peeling Back Layers of Management Complexity for Leptomeningeal Disease From EGFR-mutant Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1082-1083.
    >> Share

    July 2025
  13. MONTI S, Giuseppe P, Caroprese M, Cella L, et al
    External Validation of Dose Patterns and Dosimetric Predictors for Radiation-Induced Esophagitis in Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 31:S0360-3016(25)06043.
    >> Share

  14. LIU Y, Ma N, Li Y, Fan X, et al
    Relative Biological Effectiveness Derived from NTCP Analysis of Carbon Ion vs. Photon Radiotherapy in Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025 Jul 21:S0360-3016(25)06016.
    >> Share

  15. SAMSON P, Robinson C
    How to Avoid Collapsing Under the Pressure of Managing Atelectasis During Lung Cancer Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:785.
    >> Share

  16. MEYER S, Hu YC, Rimner A, Mechalakos J, et al
    Deformable Image Registration Uncertainty-Encompassing Dose Accumulation for Adaptive Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025;122:818-826.
    >> Share

  17. CHUONG MD, Mittauer KE, Bassetti MF, Rojas C, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy in One Fraction (SMART ONE): A Multicenter, Single-Arm, Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:957-967.
    >> Share

  18. CORN BW, Paulus R, Gondi V, Mehta MP, et al
    "Hope" Drives Quality of Life in Patients with Brain Metastases, But, the "Hope Center" Remains Elusive: An Analysis of NRG-CC003.
    Int J Radiat Oncol Biol Phys. 2025 Jul 2:S0360-3016(25)04519.
    >> Share

  19. AKDEMIR EY, Herrera R, Gurdikyan S, Hodgson LC, et al
    Stereotactic Magnetic Resonance Guided Adaptive Radiation Therapy for Infradiaphragmatic Oligometastatic Disease: Disrupting the One-Size-Fits-All Paradigm.
    Int J Radiat Oncol Biol Phys. 2025;122:739-751.
    >> Share

  20. ZHOU L, Sun J, Xie C, Kang K, et al
    Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH).
    Int J Radiat Oncol Biol Phys. 2025 Jul 1:S0360-3016(25)04508.
    >> Share

    June 2025
  21. ZHANG SC, Kehayias CE, Guthier C, He J, et al
    Differential Impact of Left Ventricular Myocardium and Left Coronary Radiation Dose with Incident Heart Failure and Coronary Events in Lung Cancer Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04493.
    >> Share

  22. DUAN J, Zhu Y, Jiang W, Wang W, et al
    Risk-Based Local Radiation Therapy in Oligometastatic Non-small Cell Lung Cancer in the Era of Immunotherapy: A Multicentric Cohort Study.
    Int J Radiat Oncol Biol Phys. 2025 Jun 25:S0360-3016(25)04499.
    >> Share

  23. ZHANG Y, Laine AM, Iyengar P, Westover KD, et al
    Concurrent and Consolidative Carboplatin Plus Nab-Paclitaxel or Paclitaxel in Locally Advanced NSCLC: A Multicenter, Randomized Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2025;122:374-382.
    >> Share

  24. OHRI N, Bodner WR, Kabarriti R, Shankar V, et al
    Randomized Evaluation of the PET-Adjusted IMRT for NSCLC Trial (REPAINT).
    Int J Radiat Oncol Biol Phys. 2025;122:365-373.
    >> Share

    May 2025
  25. KNOTH J, Nout RA, Potter R, Mahantshetty DU, et al
    Distant metastasis after chemoradiation and IGABT in locally advanced cervical cancer.
    Int J Radiat Oncol Biol Phys. 2025 May 10:S0360-3016(25)00436.
    >> Share

  26. KEANE F, Daly M, Louie A, Harris J, et al
    Resistance is Futile: Stereotactic Body Radiation Therapy for Oligoprogressive Non-small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2025;122:1-4.
    >> Share

    April 2025
  27. ALFAIFI SA, Louie AV, Siva S, Guckenberger M, et al
    International Patterns of Practice for Stereotactic Ablative Radiotherapy for Early-Stage Non-Small Cell Lung Cancer: Are We All in Sync?: Global patterns of practice for SABR for early-stage NSCLC.
    Int J Radiat Oncol Biol Phys. 2025 Apr 29:S0360-3016(25)00390.
    >> Share

  28. SIMONE CB 2ND, Amini A, Chetty IJ, Choi JI, et al
    American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-small Cell Lung Cancer Executive Summary.
    Int J Radiat Oncol Biol Phys. 2025 Apr 2:S0360-3016(25)00259.
    >> Share

  29. PAN S, Chang CW, Tian Z, Wang T, et al
    Data-Driven Volumetric Computed Tomography Image Generation From Surface Structures Using a Patient-Specific Deep Leaning Model.
    Int J Radiat Oncol Biol Phys. 2025;121:1349-1360.
    >> Share

  30. HUANG YH, Li Z, Xiong T, Chen Z, et al
    Constructing Surrogate Lung Ventilation Maps From 4-Dimensional Computed Tomography-Derived Subregional Respiratory Dynamics.
    Int J Radiat Oncol Biol Phys. 2025;121:1328-1338.
    >> Share

    March 2025
  31. COOKE SA, Belderbos JSA, Stam B, Reymen B, et al
    Esophageal Toxicity After Dose-Escalated Radiation Therapy for Stage II-III Non-Small Cell Lung Cancer: A Secondary Analysis of the Phase 2 Randomized ARTFORCE PET-Boost Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 28:S0360-3016(25)00228.
    >> Share

  32. MONTALVO SK, Lue B, Kakadiaris E, Ahn C, et al
    Global Longitudinal Strain: A Potential Non-invasive Tool for Early Detection of Radiation-Induced Cardiac Dysfunction in Lung Cancer Patients Receiving Thoracic Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2025 Mar 27:S0360-3016(25)00257.
    >> Share

  33. CHEN X, Meng F, Zhang P, Wang L, et al
    Establishing a deep learning model that integrates pre- and mid-treatment computed tomography to predict treatment response for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2025 Mar 13:S0360-3016(25)00243.
    >> Share

  34. ALLEN SG, Schonewolf CA, Schipper MJ, Yin HM, et al
    Dosimetry and Toxicity Comparison of Three-Dimensional Conformal Radiation Therapy and Intensity-Modulated Radiation Therapy in Locally Advanced Lung Cancer Across a Large Statewide Quality Collaborative.
    Int J Radiat Oncol Biol Phys. 2025 Mar 10:S0360-3016(25)00236.
    >> Share

  35. RIMNER A, Dejonckheere CS, Sahlmann J, Barth SA, et al
    Impact of Different Mediastinal Staging Modalities on Target Volume Delineation in Locally Advanced Non-Small-Cell Lung Cancer: A Secondary Analysis of the Multicenter Randomized PET-Plan Trial.
    Int J Radiat Oncol Biol Phys. 2025 Mar 5:S0360-3016(25)00196.
    >> Share

  36. BROOKS FMD, Glenn MC, Hernandez V, Saez J, et al
    Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?
    Int J Radiat Oncol Biol Phys. 2025;121:811-821.
    >> Share

    February 2025
  37. XIAO L, Li Y, Wang S, Fan L, et al
    Early prediction of radiation pneumonitis in patients with lung cancer treated with immunotherapy through monitoring of plasma chemokines.
    Int J Radiat Oncol Biol Phys. 2025 Feb 22:S0360-3016(25)00151.
    >> Share

  38. GAETA B, Eichholz JE, Walch H, Ilica AT, et al
    Intracranial disease control and survival among patients with KRAS-mutant lung adenocarcinoma and brain metastases treated with SRS.
    Int J Radiat Oncol Biol Phys. 2025 Feb 8:S0360-3016(25)00093.
    >> Share

  39. MA N, Ming X, Chen J, Jiang GL, et al
    Carbon ion radiotherapy with pencil beam scanning for stage III non-small cell lung cancer: toxicity profiles, survival outcomes, and prognostic indicators.
    Int J Radiat Oncol Biol Phys. 2025 Feb 5:S0360-3016(25)00094.
    >> Share

  40. SHIN YS, Yun JK, Jung J, Park JH, et al
    Comparison of Metastasectomy and Stereotactic Body Radiation Therapy for Pulmonary Oligometastasis From Hepatocellular Carcinoma: A Propensity Score-Weighted Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:432-441.
    >> Share

    January 2025
  41. LATIFI A, Roumeliotis M, Quirk S, Gardner UG, et al
    Brachytherapy Seed Placement by Robotic Bronchoscopy with Cone-Beam CT Guidance for Peripheral Lung Cancer: A Human Cadaveric Feasibility Pilot.
    Int J Radiat Oncol Biol Phys. 2025 Jan 25:S0360-3016(25)00078.
    >> Share

  42. NAGLER F, Vorbach S, Mohamed AA, Thaqi S, et al
    Pulmonary Stereotactic Body Radiotherapy of Oligometastatic Head-and-Neck Squamous Cell Carcinoma - A multicenter retrospective study.
    Int J Radiat Oncol Biol Phys. 2025 Jan 4:S0360-3016(24)03771.
    >> Share

  43. SCHELLENBERG D, Gabos Z, Duimering A, Debenham B, et al
    Stereotactic Ablative Radiation for Oligoprogressive Cancers: Results of the Randomized Phase 2 STOP Trial.
    Int J Radiat Oncol Biol Phys. 2025;121:28-38.
    >> Share

  44. WANG E, Abdallah H, Snir J, Chong J, et al
    Predicting the 3-Dimensional Dose Distribution of Multilesion Lung Stereotactic Ablative Radiation Therapy With Generative Adversarial Networks.
    Int J Radiat Oncol Biol Phys. 2025;121:250-260.
    >> Share

  45. WANG Y, Dong X, Yan S, Liu B, et al
    Comparison of the Long-term Survival Outcome of Surgery versus Stereotactic Body Radiation Therapy as Initial Local Treatment for Pulmonary Oligometastases from Colorectal Cancer: A Propensity Score Analysis.
    Int J Radiat Oncol Biol Phys. 2025;121:45-55.
    >> Share

    December 2024
  46. BARRETT S, Zahid MU, Enderling H, Marignol L, et al
    Predicting Individual Tumor Response Dynamics in Locally Advanced Non-Small Cell Lung Cancer Radiation Therapy: A Mathematical Modelling Study.
    Int J Radiat Oncol Biol Phys. 2024 Dec 3:S0360-3016(24)03563.
    >> Share

    November 2024
  47. KEANE FK, Yeap BY, Khandekar MJ, Lin JJ, et al
    Phase II trial of consolidative stereotactic body radiation therapy in patients with metastatic oncogene-driven non-small cell lung carcinoma treated with tyrosine kinase inhibitors.
    Int J Radiat Oncol Biol Phys. 2024 Nov 20:S0360-3016(24)03515.
    >> Share

  48. DOHOPOLSKI M, Schmitt LG, Anand S, Zhang H, et al
    Exploratory Evaluation of Personalized Ultra-Fractionated Stereotactic Adaptive Radiotherapy (PULSAR) with CNS-Active Drugs in Brain Metastases Treatment.
    Int J Radiat Oncol Biol Phys. 2024 Nov 16:S0360-3016(24)03641.
    >> Share

  49. ZHAO X, Huang S, Lin H, Choi JI, et al
    A Novel Dose Rate Optimization Method to Maximize Ultrahigh-Dose-Rate Coverage of Critical Organs at Risk Without Compromising Dosimetry Metrics in Proton Pencil Beam Scanning FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;120:1181-1191.
    >> Share

  50. SIMONE CB 2ND
    Enhancing Outcomes in Locally Advanced Non-Small Cell Lung Cancer Through Stereotactic Dose Escalation.
    Int J Radiat Oncol Biol Phys. 2024;120:695-697.
    >> Share

  51. SAMSON P, Harris JP
    Here Comes the Sun: Continuing to Refine the Treatment of Ultracentral Non-Small Cell Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:678-680.
    >> Share

  52. ZHANG S, Simard M, Lapointe A, Filion E, et al
    Evaluation of Radiation Dose Effect on Lung Function Using Iodine Maps Derived From Dual-Energy Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;120:894-903.
    >> Share

    October 2024
  53. WEISMAN M, Durm G, Shields MD, Hanna NH, et al
    Evaluation of Radiation Pneumonitis in a Phase II Study of Consolidation Immunotherapy with Nivolumab and Ipilimumab or Nivolumab Alone Following Concurrent Chemoradiotherapy for Unresectable Stage IIIA/IIIB Non-Small Cell Lung Cancer (NSCLC): Big Ten
    Int J Radiat Oncol Biol Phys. 2024 Oct 25:S0360-3016(24)03450.
    >> Share

  54. SADDOUGHI SA, Kern R
    Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) Lining: We Can All Have a Piece of the Pie.
    Int J Radiat Oncol Biol Phys. 2024;120:357-358.
    >> Share

  55. MCCALL NS, Higgins KA
    Toward the Optimal Delivery of Twice-Daily Thoracic Chemoradiation in Limited-Stage Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024;120:343-344.
    >> Share

  56. JABBOUR SK, Higgins KA, Yom SS, Goodman KA, et al
    Recapping Radiation Related Abstracts at ASCO 2024: A Commentary about the Fundamental Role of Radiation Therapy in Esophageal and Lung Cancers.
    Int J Radiat Oncol Biol Phys. 2024;120:309-314.
    >> Share

  57. LI GJ, Tan H, Nusrat H, Chang J, et al
    Safety and Efficacy of Stereotactic Body Radiation Therapy for Ultra-central Thoracic Tumors: A Single Center Retrospective Review.
    Int J Radiat Oncol Biol Phys. 2024;120:359-369.
    >> Share

  58. KAMTAM DN, Binkley MS, Kapula N, Sadeghi C, et al
    First in Human Phase 1 Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
    Int J Radiat Oncol Biol Phys. 2024;120:345-356.
    >> Share

    September 2024
  59. IGARASHI A, Onishi H, Shioyama Y, Matsumoto Y, et al
    Cost-Utility Analysis of Stereotactic Body Radiation Therapy Versus Surgery for Patients With Stage I Non-small Cell Lung Cancer in Japan.
    Int J Radiat Oncol Biol Phys. 2024 Sep 28:S0360-3016(24)03174.
    >> Share

  60. GENSHEIMER MF, Kotha NV, Vitzthum LK, Chin AL, et al
    A phase 2 single-arm trial of high-dose precision targeted radiotherapy added to immunotherapy for patients with metastatic non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 25:S0360-3016(24)03410.
    >> Share

  61. MACMANUS MP, Prins E, Xie J, Akhurst T, et al
    Dose-response relationships between radiation exposure, bone marrow function as measured by (18)F-FLT PET, and lymphocyte counts during chemoradiation for non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Sep 2:S0360-3016(24)03290.
    >> Share

  62. RANKINE LJ, Lu J, Wang Z, Kelsey CR, et al
    Quantifying Regional Radiation-Induced Lung Injury in Patients Using Hyperpolarized (129)Xe Gas Exchange Magnetic Resonance Imaging.
    Int J Radiat Oncol Biol Phys. 2024;120:216-228.
    >> Share

    August 2024
  63. ZHANG Y, Iyengar P, Montalvo S, Westover KD, et al
    Concerning safety and efficacy of concurrent and consolidative durvalumab with thoracic radiotherapy in PDL1-unselected stage III non-small cell lung cancer: brief report.
    Int J Radiat Oncol Biol Phys. 2024 Aug 13:S0360-3016(24)03177.
    >> Share

  64. TAN VS, Correa RJM, Nguyen TK, Louie AV, et al
    Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer (MISSILE): Long-Term Clinical Outcomes.
    Int J Radiat Oncol Biol Phys. 2024 Aug 8:S0360-3016(24)03173.
    >> Share

  65. GRONBERG BH
    Are We Finally Ready to Implement Twice-Daily Thoracic Radiation Therapy in Limited-Stage Small Cell Lung Cancer?
    Int J Radiat Oncol Biol Phys. 2024;119:1391-1392.
    >> Share

  66. LEAVITT RJ, Almeida A, Grilj V, Montay-Gruel P, et al
    Acute Hypoxia Does Not Alter Tumor Sensitivity to FLASH Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;119:1493-1505.
    >> Share

  67. PORTIER L, Daira P, Fourmaux B, Heinrich S, et al
    Differential Remodeling of the Oxylipin Pool After FLASH Versus Conventional Dose-Rate Irradiation In Vitro and In Vivo.
    Int J Radiat Oncol Biol Phys. 2024;119:1481-1492.
    >> Share

    July 2024
  68. HARRIS JP, Samson P, Owen D, Siva S, et al
    Adapt or Perish: Adaptive RT for NSCLC.
    Int J Radiat Oncol Biol Phys. 2024;119:1047-1051.
    >> Share

  69. LIU W, Feng H, Taylor PA, Kang M, et al
    NRG Oncology and Particle Therapy Co-Operative Group Patterns of Practice Survey and Consensus Recommendations on Pencil-Beam Scanning Proton Stereotactic Body Radiation Therapy and Hypofractionated Radiation Therapy for Thoracic Malignancies.
    Int J Radiat Oncol Biol Phys. 2024;119:1208-1221.
    >> Share

  70. EDWARDS DM, Schonewolf CA, Rice JD, Schipper M, et al
    Phase II Trial Assessing Toxicity of Personalized Response-Based Radiation Treatment in Patients with Locally Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Jul 4:S0360-3016(24)00749.
    >> Share


  71. Erratum to: Zeng Y, Liu Q, Wang Y, et al. CDK5 Activates Hippo Signaling to Confer Resistance to Radiation Therapy Via Upregulating TAZ in Lung Cancer. Int J Radiat Oncol Biol Phys 2020;108(3):758-769.
    Int J Radiat Oncol Biol Phys. 2024;119:1030-1031.
    >> Share


  72. Erratum to: Simone CB 2nd, Serebrenik AA, Gore EM, et al. Multicenter Phase 1b/2a Clinical Trial of Radioprotectant BIO 300 Oral Suspension for Patients with Non-Small Cell Lung Cancer Receiving Concurrent Chemoradiotherapy. Int J Radiat Oncol Biol Ph
    Int J Radiat Oncol Biol Phys. 2024;119:1029.
    >> Share

  73. HARRISON N, Kang M, Liu R, Charyyev S, et al
    A Novel Inverse Algorithm To Solve the Integrated Optimization of Dose, Dose Rate, and Linear Energy Transfer of Proton FLASH Therapy With Sparse Filters.
    Int J Radiat Oncol Biol Phys. 2024;119:957-967.
    >> Share

    June 2024
  74. NI J, Chen H, Yu L, Guo T, et al
    Predicting regional recurrence and prognosis in stereotactic body radiotherapy-treated clinical stage I non-small cell lung cancer using a radiomics model constructed with surgical data.
    Int J Radiat Oncol Biol Phys. 2024 Jun 25:S0360-3016(24)00743.
    >> Share

  75. CASEY DL, Vogelius IR, Brodin NP, Roberts KB, et al
    Risk of Subsequent Neoplasms in Childhood Cancer Survivors After Radiation Therapy: A PENTEC Comprehensive Review.
    Int J Radiat Oncol Biol Phys. 2024;119:640-654.
    >> Share

    May 2024
  76. LEE HI, Choi EK, Kim SS, Shin YS, et al
    Local Ablative Therapy Combined with Pembrolizumab in Patients with Synchronous Oligometastatic Non-Small Cell Lung Cancer: A Recursive Partitioning Analysis.
    Int J Radiat Oncol Biol Phys. 2024 May 24:S0360-3016(24)00674.
    >> Share

    April 2024
  77. MIDRONI J, Salunkhe R, Liu Z, Chow R, et al
    Incorporating functional lung imaging (FLI) into radiation therapy planning in patients with lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00481.
    >> Share

  78. ZHANG Q, Fan S, Xu X, Du S, et al
    Efficacy and Toxicity of Moderately Hypofractionated Radiotherapy with Helical TomoTherapy versus Conventional Radiotherapy in Patients with Unresectable Stage III Non-Small-Cell Lung Cancer Receiving Concurrent Chemotherapy: A Multicentre, Randomized
    Int J Radiat Oncol Biol Phys. 2024 Apr 15:S0360-3016(24)00450.
    >> Share

  79. MEREDITH EG, Filion E, Faria S, Kundapur V, et al
    Stereotactic Radiation for Ultra-Central Non-Small Cell Lung Cancer: A Safety and Efficacy Trial (SUNSET).
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00480.
    >> Share

  80. LOMBARDO J, Castillo E, Castillo R, Miller R, et al
    Prospective trial of Functional Lung Avoidance Radiation Therapy for Lung Cancer: Quality of Life Report.
    Int J Radiat Oncol Biol Phys. 2024 Apr 11:S0360-3016(24)00476.
    >> Share

  81. LEVIN N, Killingberg KT, Halvorsen TO, Danielsen S, et al
    Evaluation of radiotherapy treatment plans in a randomized phase II trial comparing two schedules of twice-daily thoracic radiotherapy in limited stage small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Apr 5:S0360-3016(24)00475.
    >> Share

  82. VITZTHUM LK, Surucu M, Gensheimer MF, Kovalchuk N, et al
    BIOGUIDE-X: A First-in-Human Study of the Performance of Positron Emission Tomography-Guided Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2024;118:1172-1180.
    >> Share

  83. HUANG HT, Brand DH, Fenwick JD, Hawkins MA, et al
    Immuno-chemoradiation for non-small cell lung cancer: A meta-analysis of factors influencing survival benefit in combination trials.
    Int J Radiat Oncol Biol Phys. 2024 Apr 1:S0360-3016(24)00449.
    >> Share

    March 2024
  84. KIM KH, Kang N, Song SY, Kim HJ, et al
    Safety and efficacy of HL301 in radiation pneumonitis in patients with unresectable non-small cell lung cancer receiving curative concurrent chemoradiotherapy: A multicenter, randomized, double-blinded, placebo-controlled, phase IIa clinical trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 31:S0360-3016(24)00447.
    >> Share

  85. FAROOQI AS, Yoder AK, Lin HY, Pasalic D, et al
    SABR for Sarcoma Lung Metastases: Indications for Treatment and Guidance for Patient Selection.
    Int J Radiat Oncol Biol Phys. 2024;118:971-978.
    >> Share

  86. LUCIA F, Bourhis D, Pinot F, Hamya M, et al
    Prediction of Acute Radiation-Induced Lung Toxicity After Stereotactic Body Radiation Therapy Using Dose-Volume Parameters From Functional Mapping on Gallium 68 Perfusion Positron Emission Tomography/Computed Tomography.
    Int J Radiat Oncol Biol Phys. 2024;118:952-962.
    >> Share

  87. LIU YC, Schmidt RO, Kapadia NS, Phillips JD, et al
    Disparities in access to multidisciplinary cancer consultations and treatment for early-stage non-small cell lung cancer patients: A SEER-Medicare analysis.
    Int J Radiat Oncol Biol Phys. 2024 Mar 13:S0360-3016(24)00426.
    >> Share

  88. WALLS GM, Mistry H, Barlesi F, Bezjak A, et al
    Long-term outcomes after concurrent once- or twice-daily chemoradiation in limited-stage small-cell lung cancer: a brief report from the CONVERT trial.
    Int J Radiat Oncol Biol Phys. 2024 Mar 11:S0360-3016(24)00382.
    >> Share

  89. YAN W, Ren Z, Chen X, Zhang R, et al
    Potential role of lymphocyte CD44 in determining treatment selection between stereotactic body radiotherapy and surgery for early-stage non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2024 Mar 4:S0360-3016(24)00356.
    >> Share

  90. SHUJA M, Owen D
    What if Perioperative Therapy for Non-Small Cell Lung Cancer Renders Someone Inoperable?
    Int J Radiat Oncol Biol Phys. 2024;118:587.
    >> Share

  91. FARLEY A, Nelson B
    Neoadjuvant Chemoimmunotherapy for Initially Resectable Non-Small Cell Lung Cancer: Queen's Gambit or CheckMate?
    Int J Radiat Oncol Biol Phys. 2024;118:585-586.
    >> Share

    February 2024
  92. BASCHNAGEL AM, Flakus MJ, Wallat EM, Wuschner AE, et al
    A Phase 2 Randomized Clinical Trial Evaluating 4DCT Ventilation-based Functional Lung Avoidance Radiotherapy for Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00327.
    >> Share

  93. WILLIAMS TM, Miller E, Welliver M, Brownstein J, et al
    A Phase II Trial of Primary Tumor SBRT Boost Prior to Concurrent Chemoradiation for Locally-Advanced Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2024 Feb 20:S0360-3016(24)00324.
    >> Share

  94. HAN C, Qiu J, Bai L, Liu T, et al
    Pneumonitis risk after chemoradiotherapy with and without immunotherapy in patients with locally advanced non-small cell lung cancer: A systematic review and meta-analysis.
    Int J Radiat Oncol Biol Phys. 2024 Feb 13:S0360-3016(24)00298.
    >> Share

  95. KIM H, Lee E, Cho H, Kim E, et al
    Five-Day Spacing of Two Fractionated Ablative Radiotherapies Enhances Antitumor Immunity.
    Int J Radiat Oncol Biol Phys. 2024;118:498-511.
    >> Share

    January 2024
  96. WANG J, Liu Y, Wu D, Tian C, et al
    OTUB1 targets CHK1 for deubiquitinating and stabilizing to facilitate lung cancer progression and radioresistance.
    Int J Radiat Oncol Biol Phys. 2024 Jan 22:S0360-3016(24)00246.
    >> Share

  97. TRAN PT, Mouw KW
    SABR Today . . . and Tomorrow?
    Int J Radiat Oncol Biol Phys. 2024;118:11.
    >> Share

  98. WRIGHT JL, Bazan JG
    Time to Reconsider the Role of Diagnostic Chest Computed Tomography in Early-Stage Breast Cancer?
    Int J Radiat Oncol Biol Phys. 2024;118:104-106.
    >> Share

  99. CHEN Y, Pahlavian SH, Jacobs P, Neupane T, et al
    Systematic Evaluation of the Impact of Lung Segmentation Methods on 4-Dimensional Computed Tomography Ventilation Imaging Using a Large Patient Database.
    Int J Radiat Oncol Biol Phys. 2024;118:242-252.
    >> Share

    December 2023
  100. BARTOLOMEO V, Cortiula F, Hendriks LEL, De Ruysscher D, et al
    A Glimpse Into the Future for Unresectable Stage III Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 27:S0360-3016(23)08126.
    >> Share

  101. RIMNER A, Gelblum DY, Wu AJ, Shepherd AF, et al
    Stereotactic Body Radiation Therapy for Stage IIA to IIIA Inoperable Non-small Cell Lung Cancer - A Phase I Dose Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 26:S0360-3016(23)08252.
    >> Share

  102. RAN X, Wu BX, Shi M, Song L, et al
    CRISPR screen of druggable targets in small cell lung cancer identified ATM inhibitor (AZD1390) as a radiosensitizer.
    Int J Radiat Oncol Biol Phys. 2023 Dec 15:S0360-3016(23)08245.
    >> Share

  103. VAIOS EJ, Shenker RF, Hendrickson PG, Wan Z, et al
    Long-term Intracranial Outcomes with Combination Dual Immune-Checkpoint Blockade and SRS in Patients with Melanoma and NSCLC Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2023 Dec 12:S0360-3016(23)08234.
    >> Share

  104. BASSETTI MF, Morris BA, Sethakorn N, Lang JM, et al
    Combining Dual Checkpoint Immunotherapy with Ablative Radiation to All Sites of Oligometastatic Non-Small Cell Lung Cancer: Toxicity and Efficacy Results of a Phase Ib Trial.
    Int J Radiat Oncol Biol Phys. 2023 Dec 8:S0360-3016(23)08166.
    >> Share

  105. DUDAS D, Saghad PG, Dilling TJ, Perez BA, et al
    Deep Learning-Guided Dosimetry for Mitigating Local Failure of Non-Small Cell Lung Cancer Patients Receiving SBRT.
    Int J Radiat Oncol Biol Phys. 2023 Dec 4:S0360-3016(23)08185.
    >> Share

  106. SAFAVI AH, Palma DA, Giuliani ME
    Beyond the HILUS Trial: How Can We Improve the Safety of SABR for Ultracentral Thoracic Tumors?
    Int J Radiat Oncol Biol Phys. 2023;117:1232-1235.
    >> Share

  107. SIVA S, Staehler M
    The Right Tool for the Job: The Knife, the SABR, or Fire and Ice?
    Int J Radiat Oncol Biol Phys. 2023;117:1047.
    >> Share

  108. AHN J, Yeghiaian-Alvandi R, Hegi-Johnson F, Browne LH, et al
    SABR for Early Non-Small Cell Lung Cancer: Changes in Pulmonary Function, Dyspnea, and Quality of Life.
    Int J Radiat Oncol Biol Phys. 2023;117:1213-1221.
    >> Share

  109. LINDBERG S, Grozman V, Karlsson K, Onjukka E, et al
    Expanded HILUS Trial: A Pooled Analysis of Risk Factors for Toxicity From Stereotactic Body Radiation Therapy of Central and Ultracentral Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2023;117:1222-1231.
    >> Share

  110. LEE SH, Geng H, Arnold J, Caruana R, et al
    Interpretable Machine Learning for Choosing Radiation Dose-volume Constraints on Cardio-pulmonary Substructures Associated with Overall Survival in NRG Oncology RTOG 0617.
    Int J Radiat Oncol Biol Phys. 2023;117:1270-1286.
    >> Share

    November 2023
  111. MA J, Li Y, Yu H, Zhang J, et al
    The Role of Thoracic Vertebral Body Dosimetry in Minimizing Acute Hematologic Toxicities of Non-Small Cell Lung Cancer Patients Receiving Lung Radiotherapy and Immunotherapy.
    Int J Radiat Oncol Biol Phys. 2023 Nov 29:S0360-3016(23)08165.
    >> Share

  112. VALDES G, Scholey J, Nano T, Gennatas ED, et al
    Predicting the impact of proton beam therapy technology on pulmonary toxicities for locally advanced lung cancer patients enrolled on the Proton Collaborative Group prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2023 Nov 22:S0360-3016(23)08154.
    >> Share

  113. RAMESH S, Cifci A, Javeri S, Minne R, et al
    MET Inhibitor Capmatinib Radiosensitizes MET Exon 14-Mutated and MET-Amplified Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Nov 16:S0360-3016(23)08139.
    >> Share

  114. RITTER AR, Miller ED
    No Regrets About SABR for NETs.
    Int J Radiat Oncol Biol Phys. 2023;117:786.
    >> Share

  115. OMIDI A, Weiss E, Rosu-Bubulac M, Thomas G, et al
    Quantitative analysis of radiotherapy-induced cardiac and aortic sequelae in lung cancer patients via magnetic resonance imaging: A pilot study.
    Int J Radiat Oncol Biol Phys. 2023 Nov 9:S0360-3016(23)08045.
    >> Share

  116. KUIPERS ME, van Doorn-Wink KCJ, Hiemstra PS, Slats AM, et al
    Predicting radiation-induced lung injury in lung cancer patients - challenges and opportunities: Predicting radiation-induced lung injury.
    Int J Radiat Oncol Biol Phys. 2023 Nov 2:S0360-3016(23)08049.
    >> Share

  117. HEGI-JOHNSON F, Rudd SE, Wichmann CW, Akhurst T, et al
    PD-L1 Positron Emission Tomography Imaging in Patients With Non-Small Cell Lung Cancer: Preliminary Results of the ImmunoPET Phase 0 Study.
    Int J Radiat Oncol Biol Phys. 2023;117:675-682.
    >> Share

    October 2023
  118. GAUDREAULT M, Bucknell N, Woon B, Kron T, et al
    Dose-response relationship between radiotherapy and loss of lung perfusion comparing positron emission tomography and dual-energy computed tomography in non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2023 Oct 30:S0360-3016(23)08047.
    >> Share

  119. FRIEDES C, Iocolano M, Lee SH, Li B, et al
    Patterns of Failure, Low Volume Relapse, and Subsequent Ablative Management in Locally Advanced Non-Small Cell Lung Cancer Treated with Definitive Chemoradiation and Consolidation Immune Checkpoint Inhibitors: Patterns of Failure for after PACIFIC.
    Int J Radiat Oncol Biol Phys. 2023 Oct 20:S0360-3016(23)08010.
    >> Share

  120. EDWARDS DM, Sankar K, Alseri A, Jiang R, et al
    Pneumonitis after chemoradiation and adjuvant durvalumab in stage III non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2023 Oct 2:S0360-3016(23)07971.
    >> Share

    September 2023
  121. LIU F, Ververs JD, Farris MK, William Blackstock A Jr, et al
    Optimal Radiotherapy Fractionation Regimens for Early-Stage Non-Small-Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2023 Sep 19:S0360-3016(23)07929.
    >> Share

  122. MENG Y, Sun H, Wang S, Yang H, et al
    Treatment-Related Pneumonitis of EGFR Tyrosine Kinase Inhibitors Plus Thoracic Radiotherapy in Patients with Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis.
    Int J Radiat Oncol Biol Phys. 2023 Sep 14:S0360-3016(23)07917.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016